Fresh analysis reveals that people who discontinue new GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who end traditional lifestyle programs.
Findings released in a prominent medical journal demonstrates that while overweight people frequently drop substantial amounts of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users using these medications must be cognizant of the risk of quick weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
This pace of regain implies a return to starting mass within about a year and a half.
Weighing Treatments
The research, which examined 37 of trials involving over 9,000 of participants, compared the effects of these new drugs with other pills.
Scientists note that people who lose weight through lifestyle changes alone typically have a more gradual creep back—approximately 0.1 kg a month—after stopping.
The Reason for the Rapid Rebound
Doctors propose the mode of action of the drugs accounts for the heightened rebound.
These medications mimic a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making binge eating a significant risk."
A Chronic Issue?
Medical guidelines recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the high risk of relapse, the treatment should be considered life-long.
This opinion is supported by drug manufacturers, who say that the results "underscore the persistent character of excess weight," similar to managing conditions like diabetes.
User Testimonies
People who have come off the medication report a intense resurgence of appetite.
"It felt as if a trigger flipping and you become ravenous," said a patient.
This difficulty is compounded if individuals have not established sustainable lifestyle or habit changes during treatment.
Significant Use
Survey data suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
Finally, experts stress that while these medications are potent agents for weight loss, they are not a magic solution and maintained weight loss relies on integrated lifestyle management.
